July 2020. A mystery shopper study recently published in the BMJ Sexual & Reproductive Health (PMID:32554399, Full text) explores the standard of care around accessing EC from community pharmacies in the United Kingdom. The study concludes that while availability of EC from pharmacies has improved access, the need to have a consultation with a pharmacist introduces delays; around one in five of the study mystery shoppers left without getting EC. This conclusion is in line with the Royal College of Obstetricians and Gynaecologist (RCOG) recommendation to reclassify EC pills as a General Sales List product.
Read the full study here.